ROMAIN

Biohaven's Nurtec® ODT Signs as Primary Partner with Rick Ware Racing for 2021 NTT INDYCAR Series Program

Retrieved on: 
Friday, May 14, 2021

b'MOORESVILLE, N.C., May 14, 2021 /PRNewswire/ --Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Nurtec ODT (rimegepant) willbe the primary partner for the Rick Ware Racing No.

Key Points: 
  • b'MOORESVILLE, N.C., May 14, 2021 /PRNewswire/ --Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Nurtec ODT (rimegepant) willbe the primary partner for the Rick Ware Racing No.
  • "Nurtec ODT is one, if not the only, partner in both the NASCAR Cup Series and NTT IndyCar Series, whose primary colors are on board every weekend.
  • We have created some great programs for the 2021 season, and I\'m excited to expand the program to cover the IndyCar Series full-time as well.
  • "\nVlad Coric, M.D., Chief Executive Officer of Biohaven said, "We are having a great season thus far with the NASCAR Cup Series and look forward to continuing our partnership with the Rick Ware Racing team for the NTT IndyCar Series.

SES Shareholders Approve All Resolutions at Annual General Meeting

Retrieved on: 
Thursday, April 1, 2021

SES (Euronext Paris and Luxembourg Stock Exchange: SESG) held its Annual General Meeting (AGM) today in Betzdorf, Luxembourg.

Key Points: 
  • SES (Euronext Paris and Luxembourg Stock Exchange: SESG) held its Annual General Meeting (AGM) today in Betzdorf, Luxembourg.
  • Shareholders participated remotely by appointing SES designated proxyholders to represent them at the meeting and to carry out their voting instructions given ahead of the meeting.
  • Compliance with voting instructions was verified by the bureau of the Annual General Meeting.
  • View the full release here: https://www.businesswire.com/news/home/20210401005599/en/
    SES Shareholders Approve All Resolutions at Annual General Meeting (Photo: Business Wire)
    The shareholders approved all proposed resolutions, notably the company's 2020 accounts and the proposed dividend of EUR 0.40 per A-share, which will be paid to shareholders on 22 April 2021.